Literature DB >> 24806225

Lessons learned from vivo-morpholinos: How to avoid vivo-morpholino toxicity.

David P Ferguson1, Lawrence J Dangott2, J Timothy Lightfoot3.   

Abstract

Vivo-morpholinos are a promising tool for gene silencing. These oligonucleotide analogs transiently silence genes by blocking either translation or pre-mRNA splicing. Little to no toxicity has been reported for vivo-morpholino treatment. However, in a recent study conducted in our lab, treatment of mice with vivo-morpholinos resulted in high mortality rates. We hypothesized that the deaths were the result of oligonucleotide hybridization, causing an increased cationic charge associated with the dendrimer delivery moiety of the vivo-morpholino. The cationic charge increased blood clot formation in whole blood treated with vivo-morpholinos, suggesting that clotting could have caused cardiac arrest in the deceased mice. Therefore, we investigate the mechanism by which some vivo-morpholinos increase mortality rates and propose techniques to alleviate vivo-morpholino toxicity.

Entities:  

Keywords:  annexin A6; blood clot formation; calsequestrin 1; vivo-morpholino

Mesh:

Substances:

Year:  2014        PMID: 24806225      PMCID: PMC4182913          DOI: 10.2144/000114167

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  38 in total

1.  Oocyte-type linker histone B4 is required for transdifferentiation of somatic cells in vivo.

Authors:  Nobuyasu Maki; Rinako Suetsugu-Maki; Shozo Sano; Kenta Nakamura; Osamu Nishimura; Hiroshi Tarui; Katia Del Rio-Tsonis; Keita Ohsumi; Kiyokazu Agata; Panagiotis A Tsonis
Journal:  FASEB J       Date:  2010-05-11       Impact factor: 5.191

2.  Potential significance of plasma viscosity and hematocrit variations in myocardial ischemia.

Authors:  R J Gordon; G K Snyder; H Tritel; W J Taylor
Journal:  Am Heart J       Date:  1974-02       Impact factor: 4.749

3.  Heterogeneous nuclear ribonucleoprotein K, an RNA-binding protein, is required for optic axon regeneration in Xenopus laevis.

Authors:  Yuanyuan Liu; Hurong Yu; Sarah K Deaton; Ben G Szaro
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

4.  An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice.

Authors:  Jeffrey J Widrick; Shan Jiang; Seung Jun Choi; Shannon T Knuth; Paul A Morcos
Journal:  Muscle Nerve       Date:  2011-10       Impact factor: 3.217

5.  Use of vivo-morpholinos for control of protein expression in the adult rat brain.

Authors:  Kathryn J Reissner; Gregory C Sartor; Elena M Vazey; Thomas E Dunn; Gary Aston-Jones; Peter W Kalivas
Journal:  J Neurosci Methods       Date:  2011-10-17       Impact factor: 2.390

6.  Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues.

Authors:  Paul A Morcos; Yongfu Li; Shan Jiang
Journal:  Biotechniques       Date:  2008-12       Impact factor: 1.993

7.  Vivo-Morpholino knockdown of alphaIIb: A novel approach to inhibit thrombocyte function in adult zebrafish.

Authors:  Seongcheol Kim; Uvaraj P Radhakrishnan; Surendra Kumar Rajpurohit; Vrinda Kulkarni; Pudur Jagadeeswaran
Journal:  Blood Cells Mol Dis       Date:  2010-01-04       Impact factor: 3.039

8.  A search for factors specifying tonotopy implicates DNER in hair-cell development in the chick's cochlea.

Authors:  Lukasz Kowalik; A J Hudspeth
Journal:  Dev Biol       Date:  2011-04-08       Impact factor: 3.582

9.  Antiviral and neuroprotective role of octaguanidinium dendrimer-conjugated morpholino oligomers in Japanese encephalitis.

Authors:  Arshed Nazmi; Kallol Dutta; Anirban Basu
Journal:  PLoS Negl Trop Dis       Date:  2010-11-23

10.  The development of the adult intestinal stem cells: Insights from studies on thyroid hormone-dependent amphibian metamorphosis.

Authors:  Yun-Bo Shi; Takashi Hasebe; Liezhen Fu; Kenta Fujimoto; Atsuko Ishizuya-Oka
Journal:  Cell Biosci       Date:  2011-09-06       Impact factor: 7.133

View more
  19 in total

1.  Effect of Tim23 knockdown in vivo on mitochondrial protein import and retrograde signaling to the UPRmt in muscle.

Authors:  Ashley N Oliveira; David A Hood
Journal:  Am J Physiol Cell Physiol       Date:  2018-06-27       Impact factor: 4.249

2.  Targeting protein translation, RNA splicing, and degradation by morpholino-based conjugates in Plasmodium falciparum.

Authors:  Aprajita Garg; Donna Wesolowski; Dulce Alonso; Kirk W Deitsch; Choukri Ben Mamoun; Sidney Altman
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-08       Impact factor: 11.205

3.  Exons 45-55 Skipping Using Mutation-Tailored Cocktails of Antisense Morpholinos in the DMD Gene.

Authors:  Yusuke Echigoya; Kenji Rowel Q Lim; Dyanna Melo; Bo Bao; Nhu Trieu; Yoshitaka Mizobe; Rika Maruyama; Kamel Mamchaoui; Jun Tanihata; Yoshitsugu Aoki; Shin'ichi Takeda; Vincent Mouly; William Duddy; Toshifumi Yokota
Journal:  Mol Ther       Date:  2019-07-26       Impact factor: 11.454

Review 4.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

Review 5.  Targeting mRNA for the treatment of facioscapulohumeral muscular dystrophy.

Authors:  Bo Bao; Rika Maruyama; Toshifumi Yokota
Journal:  Intractable Rare Dis Res       Date:  2016-08

6.  Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.

Authors:  Xin Sun; Leonard O Marque; Zachary Cordner; Jennifer L Pruitt; Manik Bhat; Pan P Li; Geetha Kannan; Ellen E Ladenheim; Timothy H Moran; Russell L Margolis; Dobrila D Rudnicki
Journal:  Hum Mol Genet       Date:  2014-07-04       Impact factor: 6.150

Review 7.  Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics.

Authors:  Markus Herkt; Thomas Thum
Journal:  Mol Ther       Date:  2020-11-12       Impact factor: 11.454

8.  Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.

Authors:  Brian C Stagg; Hironori Uehara; Nathan Lambert; Ruju Rai; Isha Gupta; Bryce Radmall; Taylor Bates; Balamurali K Ambati
Journal:  Cancers (Basel)       Date:  2014-11-26       Impact factor: 6.639

9.  Systemic antisense therapeutics inhibiting DUX4 expression ameliorates FSHD-like pathology in an FSHD mouse model.

Authors:  Ngoc Lu-Nguyen; Alberto Malerba; Shan Herath; George Dickson; Linda Popplewell
Journal:  Hum Mol Genet       Date:  2021-07-09       Impact factor: 6.150

10.  Long-term efficacy of systemic multiexon skipping targeting dystrophin exons 45-55 with a cocktail of vivo-morpholinos in mdx52 mice.

Authors:  Yusuke Echigoya; Yoshitsugu Aoki; Bailey Miskew; Dharminder Panesar; Aleksander Touznik; Tetsuya Nagata; Jun Tanihata; Akinori Nakamura; Kanneboyina Nagaraju; Toshifumi Yokota
Journal:  Mol Ther Nucleic Acids       Date:  2015-02-03       Impact factor: 10.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.